Dr. Robert Whitfield explains how molecular testing reveals bacteria in breast implant scar tissue that traditional culture methods miss. PCR and DNA sequencing detect organisms in low-metabolic states and biofilms, finding a wider range of microorganisms than conventional approaches and opening new ways to diagnose implant complications.
Tonight, I want to actually slow down our conversation and walk through what actually we learned when using molecular testing to examine the scar tissue around breast implants. And so the scar tissue is the capsule that forms around the implant. I'm not talking about specifically about the implant shell. We're going to talk about. What is the capsule? What a biofilm is? Why routine cultures can have certain limitations when organisms are living in a lower metabolic state or stuck in biofilm? How PCR and next-gen sequencing differ from cultures that are the traditional ones we're taught to use? And what our published study found. We will all, you know, remain and talk about this just openly and honestly about the findings and what they just lead us towards.
